Author Question: Why do you think the leukemias are sorted into lymphocytic and myelocytic categories? What will ... (Read 59 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
Why do you think the leukemias are sorted into lymphocytic and myelocytic categories?
 
  What will be an ideal response?

Question 2

Explain functional immunoincompetence.
 
  What will be an ideal response?



irishcancer18

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

There are only two progenitor cells that eventually produce all white cell types: a myeloid stem cell and a lymphoid stem cell. Mutations resulting in leukemia occur within the genes that drive the differentiation or maturation of these two cell lines.

Answer to Question 2

Functional immunoincompetence results from a proliferation of immature or defective cells (incompetent cells) that are not capable of carrying out their normal function. Often, a proliferation of immunoincompetent cells is accompanied by a decreased number of normal, competent cells. The decreased number of normal cells results when the over-proliferation of one cell type outcompetes normal cells for resources (space and nutrients) in the bone marrow.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library